© 2020 – 2023 AEA3 WEB | AEAƎ United Kingdom News
AEA3 WEB | AEAƎ United Kingdom News
News

NHS cancer patients denied life-saving drugs due to Brexit costs, report finds

Exclusive: Britons found to have ‘lost out’ while rest of Europe benefits from golden age of research and treatments

  • ‘Children with cancer cannot wait’: the human cost of clinical trial delays after Brexit

British cancer patients are being denied life-saving drugs and trials of revolutionary treatments are being derailed by the red tape and extra costs brought on by Brexit, a damning report warns.

Soaring numbers are being diagnosed with the disease amid a growing and ageing population, improved diagnosis initiatives and wider public awareness – making global collaborations to find new medicines essential.

Continue reading…

Related posts

Mandela grandson ‘surprised’ at Meghan wedding comparison

AEA3

Ukraine repelling intense Russian offensive in east, UK says, as Mariupol troops face ‘last hours’

AEA3

‘They were a bit abrasive’: how kids’ TV Clangers secretly swore

AEA3

Pin It on Pinterest

Share This